Acquiring Medtech IP

Originally Published MX May/June 2003

GOVERNMENTAL & LEGAL AFFAIRS

For many medtech companies, gathering an IP portfolio and managing it effectively are key tasks for company survival.

Moderated by Steve Halasey

The very existence of many medical technology companies is embodied in their portfolio of intellectual property (IP). For such companies, having clear ownership of and freedom to use their IP is the lifeblood of their product development efforts.

But the importance of IP to medtech companies doesn't stop there. Having a well-managed IP portfolio can often be a determining factor in a company's ability to attract and retain investment funding. Such a portfolio can strengthen a company's position in its core markets, or even broaden its ability to enter new fields of endeavor.